Elanco Animal Health Incorporated — Rendiconto Finanziario (NYSE:ELAN) | MetaTrader

Apri il grafico completo

Elanco Animal Health Incorporated

Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world.

Notizie

Il traffico nelle cliniche veterinarie si stabilizza a marzo dopo 18 mesi di calo, secondo Jefferies

Stifel conferma buy su Elanco, target a 32$

Elanco Animal Health (ELAN) Surges 7.6%: Is This an Indication of Further Gains?

Elanco alla conferenza Barclays: forte crescita e piani futuri

Elanco at Barclays Conference: Strong Growth and Future Plans

UBS conferma Buy su Elanco Animal Health per lo slancio dell’innovazione

Elanco Animal Health stock reaffirmed at Buy by UBS on innovation momentum

Stifel conferma rating Buy su azioni Elanco Animal Health

Stifel reiterates Buy rating on Elanco Animal Health stock

Elanco alla Conferenza TD Cowen: Crescita Strategica e Prospettive del Settore

Elanco at TD Cowen Conference: Strategic Growth and Industry Outlook

Elanco Animal Health Incorporated (ELAN) Presents at BofA Securities Animal Health Summit Transcript